Related references
Note: Only part of the references are listed.Comparison of essential medicines lists in 137 countries
Nav Persaud et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2019)
The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1.1 million adults
Pascal Geldsetzer et al.
LANCET (2019)
Fixed-dose combinations for hypertension
Sandeep P. Kishore et al.
LANCET (2018)
Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey
Meng Su et al.
LANCET (2017)
Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases
Margaret Ewen et al.
PLOS ONE (2017)
Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data
Marjan W. Attaei et al.
LANCET PUBLIC HEALTH (2017)
Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries
Veronika J. Wirtz et al.
CIRCULATION (2016)
Global Disparities of Hypertension Prevalence and Control A Systematic Analysis of Population-Based Studies From 90 Countries
Katherine T. Mills et al.
CIRCULATION (2016)
Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data
Rasha Khatib et al.
LANCET (2016)
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Mohammad H. Forouzanfar et al.
LANCET (2015)
Polypills Essential Medicines for Cardiovascular Disease Secondary Prevention?
Mark D. Huffman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Essential Medicines Are More Available than Other Medicines around the Globe
Yaser T. Bazargani et al.
PLOS ONE (2014)
Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review
Amir Shroufi et al.
BMC PUBLIC HEALTH (2013)
Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries
Clara K. Chow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration
Hans V. Hogerzeil et al.
LANCET (2013)
Availability, price and affordability of cardiovascular medicines: A comparison across 36 countries using WHO/HAI data
Maaike S. M. van Mourik et al.
BMC CARDIOVASCULAR DISORDERS (2010)
Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines
Marc Twagirumukiza et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2010)
Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis
A. Cameron et al.
LANCET (2009)
The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries
Shanthi Mendis et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2007)
25 years of the WHO essential medicines lists: progress and challenges
R Laing et al.
LANCET (2003)
Share Paper
